CTLA4 and neoplasm: Leach et al. demonstrated that blocking the CTLA-4 receptor led to an increased anti-tumor immune response, suggesting that tumor cells are capable of upregulating CTLA-4 in the tumor microenvironment to avoid detection by the immune system [16].